Bases epidemiológicas y mecanismos moleculares implicados en las asociaciones de obesidad y diabetes con cáncer

Gallagher, 2015, Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality, Physiol Rev., 95, 727, 10.1152/physrev.00030.2014

Association, 2013, Diagnosis and classification of diabetes mellitus, Diabetes Care., 36, S67, 10.2337/dc13-S067

Tannenbaum, 1940, Relationship of body weight to cancer incidence, Arch Pathol., 30, 509

Font-Burgada, 2016, Obesity and cancer: The oil that feeds the flame, Cell Metab., 23, 48, 10.1016/j.cmet.2015.12.015

Wang, 2014, Body mass index and risk of renal cell cancer: A dose-response meta-analysis of published cohort studies, Int J Cancer., 135, 1673, 10.1002/ijc.28813

Alsamarrai, 2014, Factors that affect risk for pancreatic disease in the general population: A systematic review and meta-analysis of prospective cohort studies, Clin Gastroenterol Hepatol., 12, 1635, 10.1016/j.cgh.2014.01.038

Rui, 2012, Excess body mass index and risk of liver cancer: a nonlinear dose-response meta-analysis of prospective studies, PloS one., 7, e44522, 10.1371/journal.pone.0044522

Okabayashi, 2012, Body mass index category as a risk factor for colorectal adenomas: A systematic review and meta-analysis, Am J Gastroenterol., 107, 1175, 10.1038/ajg.2012.180

Munsell, 2014, Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status, Epidemiol Rev., 36, 114, 10.1093/epirev/mxt010

Olsen, 2007, Obesity and the risk of epithelial ovarian cancer: A systematic review and meta-analysis, Eur J Cancer., 43, 690, 10.1016/j.ejca.2006.11.010

Zhao, 2012, Overweight, obesity and thyroid cancer risk: A meta-analysis of cohort studies, J Int Med Res., 40, 2041, 10.1177/030006051204000601

Hu, 2014, Obesity has multifaceted impact on biochemical recurrence of prostate cancer: A dose-response meta-analysis of 36,927 patients, Med Oncol., 31, 829, 10.1007/s12032-013-0829-8

Lin, 2014, Body mass index and risk of gastric cancer: A meta-analysis, Jpn J Clin Oncol., 44, 783, 10.1093/jjco/hyu082

Siegel, 2015, Cancer statistics, 2015, CA Cancer J Clin., 65, 5, 10.3322/caac.21254

García-Jiménez, 2016, From obesity to diabetes and cancer: Epidemiological links and role of therapies, Br J Cancer., 114, 716, 10.1038/bjc.2016.37

Tsilidis, 2015, Type 2 diabetes and cancer: Umbrella review of meta-analyses of observational studies, BMJ., 350, g7607, 10.1136/bmj.g7607

Habib, 2013, Diabetes and risk of cancer, ISRN Oncol., 2013, 583786

Yang, 2013, Obesity and incidence of lung cancer: A meta-analysis, Int J Cancer., 132, 1162, 10.1002/ijc.27719

Simon, 2010, Diabetes mellitus, hyperglycaemia and cancer, Diabetes Metab., 36, 182, 10.1016/j.diabet.2010.04.001

Shikata, 2013, Diabetes mellitus and cancer risk: Review of the epidemiological evidence, Cancer Sci., 104, 9, 10.1111/cas.12043

Shu, 2010, Cancer risk among patients hospitalized for Type 1 diabetes mellitus: A population-based cohort study in Sweden, Diabet Med., 27, 791, 10.1111/j.1464-5491.2010.03011.x

Pezzilli, 2013, Is diabetes mellitus a risk factor for pancreatic cancer?, World J Gastroenterol., 19, 4861, 10.3748/wjg.v19.i30.4861

Smith, 2009, Does diabetes therapy influence the risk of cancer?, Diabetologia., 52, 1699, 10.1007/s00125-009-1441-5

Hemkens, 2009, Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: A cohort study, Diabetologia., 52, 1732, 10.1007/s00125-009-1418-4

Fraenkel, 2008, mTOR inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes, Diabetes., 57, 945, 10.2337/db07-0922

Djiogue, 2013, Insulin resistance and cancer: The role of insulin and IGFs, Endocr Relat Cancer., 20, R1, 10.1530/ERC-12-0324

Gallagher, 2010, The proliferating role of insulin and insulin-like growth factors in cancer, Trends Endocrinol Metab., 21, 610, 10.1016/j.tem.2010.06.007

Li, 2004, Expression of liver insulin-like growth factor 1 gene and its serum level in patients with diabetes, World J Gastroenterol., 10, 255, 10.3748/wjg.v10.i2.255

Onitilo, 2012, Diabetes and cancer I: Risk, survival, and implications for screening, Cancer Causes Control., 23, 967, 10.1007/s10552-012-9972-3

Palta, 2014, The trajectory of IGF-1 across age and duration of type 1 diabetes, Diabetes Metab Res Rev., 30, 777, 10.1002/dmrr.2554

Chen, 2013, IGF-1R as an anti-cancer target — trials and tribulations, Chin J Cancer., 32, 242, 10.5732/cjc.012.10263

Kaplan, 2012, Re: Association of clinical benign prostate hyperplasia with prostate cancer incidence and mortality revisited: A nationwide cohort study of 3,009,258 men, J Urol., 188, 898, 10.1016/j.juro.2012.05.069

Koroljow, 1962, Two cases of malignant tumors with metastases apparently treated successfully with hypoglycemic coma, Psychiatr Q., 36, 261, 10.1007/BF01586115

Lopez-Jaramillo, 2014, The role of leptin/adiponectin ratio in metabolic syndrome and diabetes, Horm Mol Biol Clin Investig., 18, 37

Sahu, 2003, Leptin signaling in the hypothalamus: Emphasis on energy homeostasis and leptin resistance, Front Neuroendocrinol., 24, 225, 10.1016/j.yfrne.2003.10.001

Garofalo, 2006, Leptin and cancer, J Cell Physiol., 207, 12, 10.1002/jcp.20472

Boden, 1996, Effect of fasting on serum leptin in normal human subjects, J Clin Endocrinol Metab., 81, 3419

Cleary, 2004, Leptin receptor-deficient MMTV-TGF-alpha/Lepr(db)Lepr(db) female mice do not develop oncogene-induced mammary tumors, Exp Biol Med (Maywood)., 229, 182, 10.1177/153537020422900207

Trayhurn, 2004, Adipokines: Inflammation and the pleiotropic role of white adipose tissue, Br J Nutr., 92, 347, 10.1079/BJN20041213

Kelesidis, 2006, Adiponectin and cancer: A systematic review, Br J Cancer., 94, 1221, 10.1038/sj.bjc.6603051

Dalamaga, 2012, The role of adiponectin in cancer: A review of current evidence, Endocr Rev., 33, 547, 10.1210/er.2011-1015

Kim, 2010, Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation, Mol Endocrinol., 24, 1441, 10.1210/me.2009-0498

Gialamas, 2011, Serum adiponectin levels and tissue expression of adiponectin receptors are associated with risk, stage, and grade of colorectal cancer, Metab Clin Exp., 60, 1530, 10.1016/j.metabol.2011.03.020

Mantzoros, 2004, Adiponectin and breast cancer risk, J Clin Endocrinol Metab., 89, 1102, 10.1210/jc.2003-031804

Saxena, 2010, Metastasis suppression by adiponectin: LKB1 rises up to the challenge, Cell Adh Migr., 4, 358, 10.4161/cam.4.3.11541

Grivennikov, 2011, Inflammatory cytokines in cancer: Tumour necrosis factor and interleukin 6 take the stage, Ann Rheum Dis., 70, 10.1136/ard.2010.140145

Hoffmann, 2006, Circuitry of nuclear factor kappaB signaling, Immunol Rev., 210, 171, 10.1111/j.0105-2896.2006.00375.x

Yu, 2009, STATs in cancer inflammation and immunity: A leading role for STAT3, Nat Rev Cancer., 9, 798, 10.1038/nrc2734

Allavena, 2012, Immunology in the clinic review series; focus on cancer: Tumour-associated macrophages: Undisputed stars of the inflammatory tumour microenvironment, Clin Exp Immunol., 167, 195, 10.1111/j.1365-2249.2011.04515.x

Haabeth, 2012, A model for cancer-suppressive inflammation, Oncoimmunology., 1, 1146, 10.4161/onci.21542

Vives-Pi, 2015, How apoptotic β-cells direct immune response to tolerance or to autoimmune diabetes: A review, Apoptosis., 20, 263, 10.1007/s10495-015-1090-8

Geerlings, 1999, Immune dysfunction in patients with diabetes mellitus (DM), FEMS Immunol Med Microbiol., 26, 259, 10.1111/j.1574-695X.1999.tb01397.x

Taubes, 2012, Cancer research. Unraveling the obesity-cancer connection, Science., 335, 28, 10.1126/science.335.6064.28

Chocarro-Calvo, 2013, Glucose-induced beta-catenin acetylation enhances Wnt signaling in cancer, Mol Cell., 49, 474, 10.1016/j.molcel.2012.11.022

Yamasaki, 2010, Insulin-independent promotion of chemically induced hepatocellular tumor development in genetically diabetic mice, Cancer Sci., 101, 65, 10.1111/j.1349-7006.2009.01345.x

Masur, 2011, Diabetogenic glucose and insulin concentrations modulate transcriptome and protein levels involved in tumour cell migration, adhesion and proliferation, Br J Cancer., 104, 345, 10.1038/sj.bjc.6606050

Brownlee, 2001, Biochemistry and molecular cell biology of diabetic complications, Nature., 414, 813, 10.1038/414813a

Martinez-Outschoorn, 2013, Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment: RAS and NFkappaB target stromal MCT4, Cell Cycle., 12, 2580, 10.4161/cc.25510

Pylayeva-Gupta, 2011, RAS oncogenes: Weaving a tumorigenic web, Nat Rev Cancer., 11, 761, 10.1038/nrc3106

Ray, 2012, Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling, Cell Signal., 24, 981, 10.1016/j.cellsig.2012.01.008

Ward, 2012, Metabolic reprogramming: A cancer hallmark even warburg did not anticipate, Cancer Cell., 21, 297, 10.1016/j.ccr.2012.02.014